In AML with a high expression of ZEB1, AML is closely correlated with poor patient prognosis, and mechanistically, it was found that ZEB1 can interact with P53 and can regulate the PTEN/PI3K/AKT signaling pathway [53]. The gene discussed is ZEB1; the disease is acute myeloid leukemia.